Literature DB >> 21574206

The statistical pitfalls of the partially randomized preference design in non-blinded trials of psychological interventions.

Isla Gemmell1, Graham Dunn.   

Abstract

In a partially randomized preference trial (PRPT) patients with no treatment preference are allocated to groups at random, but those who express a preference receive the treatment of their choice. It has been suggested that the design can improve the external and internal validity of trials. We used computer simulation to illustrate the impact that an unmeasured confounder could have on the results and conclusions drawn from a PRPT. We generated 4000 observations ("patients") that reflected the distribution of the Beck Depression Index (DBI) in trials of depression. Half were randomly assigned to a randomized controlled trial (RCT) design and half were assigned to a PRPT design. In the RCT, "patients" were evenly split between treatment and control groups; whereas in the preference arm, to reflect patient choice, 87.5% of patients were allocated to the experimental treatment and 12.5% to the control. Unadjusted analyses of the PRPT data consistently overestimated the treatment effect and its standard error. This lead to Type I errors when the true treatment effect was small and Type II errors when the confounder effect was large. The PRPT design is not recommended as a method of establishing an unbiased estimate of treatment effect due to the potential influence of unmeasured confounders.
Copyright © 2011 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2011        PMID: 21574206      PMCID: PMC6878315          DOI: 10.1002/mpr.326

Source DB:  PubMed          Journal:  Int J Methods Psychiatr Res        ISSN: 1049-8931            Impact factor:   4.035


  24 in total

1.  An inventory for measuring depression.

Authors:  A T BECK; C H WARD; M MENDELSON; J MOCK; J ERBAUGH
Journal:  Arch Gen Psychiatry       Date:  1961-06

Review 2.  Understanding controlled trials. What is a patient preference trial?

Authors:  D J Torgerson; B Sibbald
Journal:  BMJ       Date:  1998-01-31

3.  The influence of patient preference on depression treatment in primary care.

Authors:  Patricia Lin; Duncan G Campbell; Edmund F Chaney; Chuan-Fen Liu; Patrick Heagerty; Bradford L Felker; Susan C Hedrick
Journal:  Ann Behav Med       Date:  2005-10

4.  Patient preferences in randomised trials: threat or opportunity?

Authors:  D J Torgerson; J Klaber-Moffett; I T Russell
Journal:  J Health Serv Res Policy       Date:  1996-10

5.  Assessing effectiveness of treatment of depression in primary care. Partially randomised preference trial.

Authors:  N Bedi; C Chilvers; R Churchill; M Dewey; C Duggan; K Fielding; V Gretton; P Miller; G Harrison; A Lee; I Williams
Journal:  Br J Psychiatry       Date:  2000-10       Impact factor: 9.319

6.  Randomised controlled trial of non-directive counselling, cognitive-behaviour therapy and usual general practitioner care in the management of depression as well as mixed anxiety and depression in primary care.

Authors:  M King; B Sibbald; E Ward; P Bower; M Lloyd; M Gabbay; S Byford
Journal:  Health Technol Assess       Date:  2000       Impact factor: 4.014

7.  Antidepressant drugs and generic counselling for treatment of major depression in primary care: randomised trial with patient preference arms.

Authors:  C Chilvers; M Dewey; K Fielding; V Gretton; P Miller; B Palmer; D Weller; R Churchill; I Williams; N Bedi; C Duggan; A Lee; G Harrison
Journal:  BMJ       Date:  2001-03-31

Review 8.  Designing medical and educational intervention studies. A review of some alternatives to conventional randomized controlled trials.

Authors:  C Bradley
Journal:  Diabetes Care       Date:  1993-02       Impact factor: 19.112

9.  Meta-analysis of data on costs from trials of counselling in primary care: using individual patient data to overcome sample size limitations in economic analyses.

Authors:  Peter Bower; Sarah Byford; Julie Barber; Jennifer Beecham; Sharon Simpson; Karin Friedli; Roslyn Corney; Michael King; Ian Harvey
Journal:  BMJ       Date:  2003-06-07

10.  Modelling treatment-effect heterogeneity in randomized controlled trials of complex interventions (psychological treatments).

Authors:  Graham Dunn; Richard Bentall
Journal:  Stat Med       Date:  2007-11-20       Impact factor: 2.373

View more
  6 in total

1.  Improving study design for antidepressant effectiveness assessment.

Authors:  Florian Naudet; Bruno Millet; Jean Michel Reymann; Bruno Falissard
Journal:  Int J Methods Psychiatr Res       Date:  2013-08-30       Impact factor: 4.035

2.  Outcomes of a Culturally Tailored Partially Randomized Patient Preference Controlled Trial to Increase Physical Activity Among Low-Income Immigrant Latinas.

Authors:  Karen T D'Alonzo; Barbara A Smith; Lee H Dicker
Journal:  J Transcult Nurs       Date:  2017-07-27       Impact factor: 1.959

3.  Association of Patient Treatment Preference With Dropout and Clinical Outcomes in Adult Psychosocial Mental Health Interventions: A Systematic Review and Meta-analysis.

Authors:  Emma Windle; Helena Tee; Alina Sabitova; Nikolina Jovanovic; Stefan Priebe; Catherine Carr
Journal:  JAMA Psychiatry       Date:  2020-03-01       Impact factor: 21.596

4.  Revisiting a non-significant findings study: a parent mentor intervention trial as exemplar.

Authors:  Susan Sullivan-Bolyai; Carol Bova; Lesley Lowes; Sue Channon
Journal:  Appl Nurs Res       Date:  2014-02-10       Impact factor: 2.257

5.  Patients' treatment expectancies in clinical trials of antidepressants versus psychotherapy for depression: a study using hypothetical vignettes.

Authors:  Brandon A Gaudiano; Jessica A Hughes; Ivan W Miller
Journal:  Compr Psychiatry       Date:  2012-07-13       Impact factor: 3.735

Review 6.  Low protein diets in patients with chronic kidney disease: a bridge between mainstream and complementary-alternative medicines?

Authors:  Giorgina Barbara Piccoli; Irene Capizzi; Federica Neve Vigotti; Filomena Leone; Claudia D'Alessandro; Domenica Giuffrida; Marta Nazha; Simona Roggero; Nicoletta Colombi; Giuseppe Mauro; Natascia Castelluccia; Adamasco Cupisti; Paolo Avagnina
Journal:  BMC Nephrol       Date:  2016-07-08       Impact factor: 2.388

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.